The bond market has caught a bid over much of the past month, with buyers stepping into a crucial part of the $30 trillion Treasury market partly because of anxiety over artificial intelligence’s potential to wipe out many U.S. jobs,...
Novo Nordisk shares were under pressure on Monday as the struggling Danish pharmaceutical said a head-to-head study found a drug in development didn’t cut as much weight as an Eli Lilly product. Source link...
Grail’s stock was the Nasdaq’s biggest loser Friday, after a key trial of its Galleri early-detection cancer test failed to meet its primary endpoint. Source link...
Some experts say Florida’s more business-friendly policies are helping the state attract more corporations. Source link...
Want to pay rent in two installments instead of one? The fine print can make “0% interest” costlier than it sounds. Source link...
Fewer power outages led to disappointing residential sales for Generac, but investors cheered the jump in sales to data centers. Source link...
Why the artificial-intelligence advertising spree could be the last hurrah — like the dot-coms in 2000. Source link...
The compounded pill is less expensive than the oral version of Wegovy, which costs $149 to get started. Source link...
Palantir’s guidance vastly exceeds expectations, with the company projecting 61% growth for the year Source link...
“My home is paid for and has an estimated value of $700,000.” Source link...
